LAT8881

DRUG3 trials

Sponsors

Lateral Pharma Pty Ltd

Conditions

Acute MigraineDiabetic Peripheral Neuropathy (DPN)Neuropathic PainPost Herpetic Neuralgia (PHN)Radiculopathy Lumbar

Phase 1

A Two-part Proof-of-Concept Study Assessing the Safety and Efficacy of LAT8881 in Lumbar Radicular Pain

CompletedNCT05298306

Lateral Pharma Pty LtdRadiculopathy Lumbar

Start: 2022-05-17End: 2023-06-16Updated: 2024-11-27

Phase 2

Oral LAT8881 in Neuropathic Pain

CompletedNCT03865953

Lateral Pharma Pty LtdDiabetic Peripheral Neuropathy (DPN), Neuropathic Pain, Post Herpetic Neuralgia (PHN)

Start: 2019-04-09End: 2020-05-03Updated: 2021-06-14

A Proof of Concept Study of the Efficacy and Safety of Oral LAT8881 in Acute Migraine

CompletedNCT04153409

Lateral Pharma Pty LtdAcute Migraine

Start: 2019-09-24End: 2020-04-10Updated: 2021-04-28